[Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe

Jing-Liao Zhang1, Tian-Feng Liu, Li-Xian Chang

  • 1Department of Pediatric Blood Diseases, Institute of Hematology & Blood Disease Hospotial, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China. xfzhu@ihcams.ac.cn.

Insights

Children with severe/very severe aplastic anemia (SAA/VSAA) receiving immunosuppressive therapy (IST) face risks of clonal evolution. High CD3+ T cell percentage or lack of IST response predict unfavorable progressions, impacting survival outcomes.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Immunosuppression Therapy

Background:

  • Severe/very severe aplastic anemia (SAA/VSAA) is a life-threatening condition.
  • Immunosuppressive therapy (IST) is a standard treatment for SAA/VSAA.
  • Clonal evolution can occur after IST, leading to adverse outcomes.

Purpose of the Study:

  • To investigate the clinical characteristics of clonal evolution after IST in pediatric SAA/VSAA.
  • To identify risk factors associated with unfavorable clonal evolution post-IST.

Main Methods:

  • Retrospective analysis of clinical data from 231 children with newly-diagnosed SAA/VSAA treated with IST.
  • Evaluation of the incidence and risk factors for clonal evolution, including cytogenetic abnormalities and paroxysmal nocturnal hemoglobinuria (PNH) clones.
  • Univariate and Cox multivariate analyses to determine independent risk factors for unfavorable progressions.

Main Results:

  • The 5-year overall survival rate was 82.7%.
  • Fifteen patients experienced clonal evolution post-IST, with 5 favorable (PNH and trisomy 8) and 10 unfavorable (monosomy 7, MDS/AML) progressions.
  • Independent risk factors for unfavorable progressions included elevated CD3+ T cell percentage (>80%) and lack of response to IST.

Conclusions:

  • Children with SAA/VSAA and a high CD3+ T cell percentage at diagnosis are at increased risk of unfavorable progressions.
  • Lack of response to IST is a significant predictor of adverse outcomes in pediatric SAA/VSAA patients.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.9K